Pharmacology News
Health, Fitness & Longevity
About
Join Dr. Carlos on “Pharmacology Insights,” your source for the latest research and news on pharmacology, medications, and street drugs. Each episode delves into cutting-edge discoveries, practical applications, and the evolving landscape of both legal and illicit substances. Gain a deeper understanding of how drugs work, their impacts on health, and the latest trends in medication and drug use. Tune in for expert analysis and insightful discussions that keep you informed on all things pharmacological.
Episodes
- Antidepressants and Suicide Prevention: Lessons from Korea’s 2002 Prescription Restrictions
A recent study examines how South Korea’s 2002 limits on SSRI prescribing by primary care physicians coincided with a striking rise in national suicide rates. This episode reviews the Korean evidence alongside international research on ant…
- Silent Slip: How Medications Are Fueling Falls in Our Elderly
This episode explores the alarming link between common medications and falls among older adults, revealing how psychotropics and polypharmacy contribute to up to three-quarters of incidents in nursing homes. Drawing on key studies, it deta…
- The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study
In the ER, seconds matter when identifying the "Dangerous Tetrad": rigidity, fever, autonomic instability, and altered mentation. This episode breaks down the clinical markers and pathophysiology of these life-threatening syndromes to help…
- Antidepressant Withdrawal: 50% of Long-Term Users Suffer? Shocking JAMA Study vs Real-World Reality Exposed
Psychiatrists are clashing over antidepressant withdrawal: clinic data shows up to 50% of long-term SSRI/SRI users face severe symptoms, while a major 2025 JAMA Psychiatry meta-analysis claims they’re usually mild and brief. We break down…
- Metabolic Brake or Muscle Catalyst? The Pharmacokinetics of GLP-1 Muscle Loss
While GLP-1 receptor agonists are not inherently "muscle-toxic," the rapid metabolic shift they induce can lead to a catabolic state that consumes lean tissue. In this episode, we dive into the pharmacology of semaglutide and tirzepatide,…
- Ibogaine: Miracle Cure or Medical Gamble? The Truth Behind a Controversial Psychedelic
This episode explores ibogaine as a controversial psychedelic treatment for addiction, examining its reported effects on opioid withdrawal, cravings, and psychological insight alongside serious cardiac and neurological risks. It provides a…
- Low-Dose Methamphetamine Neuroprotection: What the Studies Actually Show
- The Messy Truth About Antidepressants: Benefits, Risks, and the Limits of the Evidence
Antidepressants demonstrate modest but real benefits for moderate-to-severe depression, with large meta-analyses showing consistent advantages over placebo and meaningful improvements in function for many patients, yet these gains are ofte…
- Why One ADHD Medication Hits Kids So Differently — And How Genetics Can Help
- Artificial intelligence begins prescribing medications in Utah
- Marijuana and emphysema
- Ketamine and neurotoxicity
- New study on lithium
- Is low-dose quetiapine safe for insomnia?
- How assessments can increase antidepressant prescriptions
- Saffron being studied for insomnia
- Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.
- IS THERE A DIFFERENCE BETWEEN THE INJECTABLE OR ORAL NALTREXONE AND TREATMENT
- A LOOK AT BIRTH CONTROL TO DEPRESSION TO ANTIDEPRESSANTS
- PRAMIPEXOLE FOR TREATMENT RESISTANT DEPRESSION
- ABILIFY COULD LEAD TO GAMBLING ADDICTION
- VARENICLINE POSSIBLY COULD HELP WITH ALCOHOL USE DISORDER
- ANTIDEPRESSANTS DURING PREGNANCY MAY ALTER FETAL DEVELOPMENT
- LEVETIRACETAM POSSIBLE ADJUNCT FOR BIPOLAR MANIA
- A STUDY ON ANTIPSYCHOTICS
- TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS
- PSILOCYBIN USE SKYROCKETS
- A POSSIBLE NEW TREATMENT FOR SCHIZOPHRENIA
- ATOMOXETINE, AMPHETAMINES FOR SCHIZOPHRENIA STUDY
- HOW SSRI MIGHT AFFECT HEART DEVELOPMENT
- ANTIPSYCHOTICS HELPS WITH CANNABIS INDUCED PSYCHOSIS
- CLOZAPINE AND HYPERSALIVATION
- PIMAVANSERIN DOES IT HELP WITH SCHIZOPHRENIA AND NEGATIVE SYMPTOMS
- CANNABIS AND HEART DISEASE
- DR. MONCRIEFF HER NEW BOOK CHEMICALLY IMBALANCED
- A BRIEF LOOK AT SOME NEW PSYCHEDELIC RESEARCH
- WEIGHT LOSS DRUGS CAN HELP YOUR HEALTH IN MANY WAYS BUT THERE ARE CONCERNS
- NEW ANTI-PSYCHOTIC FOR SCHIZOPHRENIA
- WE LOOK AT ANTIPSYCHOTIC SIDE EFFECTS
- A STUDY ON ANTIPSYCHOTICS
- WE CHAT WITH DR. ARMSTRONG ABOUT PSYCHEDELICS
- DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP
- LITHIUM COULD PREVENT HOSPITALIZATION
- FDA REJECTS MDMA
- CAN OZEMPIC HELP WITH ADDICTION
- TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS AND WHAT TO DO ABOUT IT3
- STUDY LOOKS AT MAINTENANCE OPIOID THERAPY BUPRENORPHINE
- IS LITHIUM EFFECTIVE IN REDUCING SUICIDE COMPLETIONS
- STUDY SHOWS OZEMPIC LINKED TO POTENTIAL VISION LOSS
- EVOLUTIONARY PSYCHIATRY WITH DR.NESSE